| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9313543 | Urology | 2005 | 4 Pages |
Abstract
The results of our study have demonstrated that DRE is a significant barrier to participation in PCa screening. PSA plus DRE-based programs result in fewer cases of PCa detected, with a significant increase in negative biopsies. We, therefore, suggest that future mass screening efforts include only PSA determination and omit the DRE.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Harris M. Nagler, Eric W. Gerber, Peter Homel, Joseph R. Wagner, Jennifer Norton, Steven Lebovitch, John L. Phillips,